Published May 2000 | Version v1
Journal article Metadata-only

The perspective on application of prevented vascular restenosis by radionuclide antisense therapy

Creators

  • 1. The Fourth Military Medical Univ., Xi'an (China). Xijing Hospital, Dept. of Nuclear Medicine

Description

The current status in preventing vascular restenosis are given in brief. The perspective on the application and superiority of radionuclide antisense therapy in the prevention and treatment of vascular restenosis are expounded emphatically, and the selection of radionuclides to label anti-sense oligonucleotides is also discussed

Additional details

Publishing Information

Journal Title
Journal of Isotopes
Journal Volume
13
Journal Issue
2
Journal Page Range
p. 111-114
ISSN
1000-7512

INIS

Country of Publication
China
Country of Input or Organization
China
INIS RN
32018474
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
INDIUM 111; IODINE 125; IRIDIUM 192; NUCLEAR MEDICINE; NUCLEOTIDES; PHOSPHORUS 32; RADIOISOTOPES; RADIOTHERAPY; RHENIUM 186; RHENIUM 188; STRONTIUM 90; TECHNETIUM 99; VASCULAR DISEASES; YTTRIUM 90
Descriptors DEC
ALKALINE EARTH ISOTOPES; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; DAYS LIVING RADIOISOTOPES; DISEASES; ELECTRON CAPTURE RADIOISOTOPES; EVEN-EVEN NUCLEI; HEAVY NUCLEI; HOURS LIVING RADIOISOTOPES; INDIUM ISOTOPES; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; IODINE ISOTOPES; IRIDIUM ISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LIGHT NUCLEI; MEDICINE; MINUTES LIVING RADIOISOTOPES; NUCLEAR MEDICINE; NUCLEI; ODD-EVEN NUCLEI; ODD-ODD NUCLEI; ORGANIC COMPOUNDS; PHOSPHORUS ISOTOPES; RADIOISOTOPES; RADIOLOGY; RHENIUM ISOTOPES; STRONTIUM ISOTOPES; TECHNETIUM ISOTOPES; THERAPY; YEARS LIVING RADIOISOTOPES; YTTRIUM ISOTOPES